BioNTech SE (BNTX)
109.84
-1.04
(-0.94%)
USD |
NASDAQ |
Feb 25, 16:00
109.56
-0.28
(-0.25%)
After-Hours: 20:00
BioNTech Research and Development Expense (Quarterly) : 660.04M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CureVac NV | 44.70M |
| Merck & Co., Inc. | 3.992B |
| Novavax, Inc. | 98.17M |
| Pfizer Inc. | 3.206B |
| Moderna, Inc. | 708.00M |